Biotech: venture funds and startups
Sector hub · Health
◆ Funds tracked
135
◆ Combined AUM
$140.6B
◆ Startups tracked
68
◆ Raised between them
$680.6M
◆ Overview
Fusion42 tracks 135 venture funds in Biotech with $140.6B in combined assets under management, and 68 startups that have raised $680.6M between them. The data below is live from the same database that powers Raise and Scout, and is continuously enriched as new rounds and funds are announced.
Part of the Raise fund database and the Scout startup database by Fusion42 — the same live data Arthur reasons over.
◆ Highlights
Active funds in Biotech include NeoGenesis Capital, Panakès Fund – Fondo Parallelo Lombardia, CapeHaven, MSIV Fund II and Solari Capital; startups in Biotech include Estuary Biotherapeutics, Giraffe Bio, Metabolize, OlsAro and Molagri. Each name links through to a full machine-readable profile — its backers, rounds and related Wire analysis — and the tables below list every entity Fusion42 tracks in Biotech, refreshed as new rounds and funds are announced.
◆ Funds in Biotech (135 tracked)
| Fund | Type | HQ |
|---|---|---|
| NeoGenesis Capital | vc | United States |
| Panakès Fund – Fondo Parallelo Lombardia | vc | Italy |
| CapeHaven | vc | United States |
| MSIV Fund II | vc | United States |
| Solari Capital | vc | United States |
| Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII | vc | Netherlands |
| NVM Ventures | vc | Italy |
| Primo Biotech Lazio | vc | Italy |
| Bain Capital Ventures Fund XI | vc | United States |
| LumaBio Fund I | vc | United States |
| UNC Health Ventures | corporate vc | United States |
| GD1 Core Fund II | vc | New Zealand |
| Adverb Ventures | vc | United States |
| offshore RMB venture fund | vc | Hong Kong |
| Draper X Ventures | vc | South Korea |
| Fresenius Ventures | corporate vc | Germany |
| Fresenius Ventures | corporate vc | Germany |
| Khosla Ventures Funds | vc | United States |
| Dimension III | vc | United States |
| Groove Capital | vc | United States |
| Nava Ventures | vc | United States |
| Samsung Ventures | vc | South Korea |
| National Security Strategic Investment Fund | vc | United Kingdom |
| Redstart Labs | vc | India |
| AlleyCorp Fund II | vc | United States |
Show all 50 funds
| Norrsken Evolve | vc | Denmark |
| a16z Scout Fund | vc | United States |
| Premier Partners | vc | South Korea |
| SFC Capital | vc | United Kingdom |
| IMM Investment | vc | South Korea |
| NTHU Future Fund | vc | Taiwan |
| Aspire11 | vc | Czech Republic |
| Amplify Partners | vc | United States |
| Octopus Ventures | vc | United Kingdom |
| Premji Invest | vc | India |
| Criteria Bio Ventures and Criteria Venture Tech | vc | Spain |
| Criteria Bio Ventures | vc | Spain |
| Yosemite Fund II | vc | United States |
| Marin Sonoma Impact Ventures | vc | United States |
| Peers Capital Preventive Health Syndicate | vc | Switzerland |
| Genesys University Seed Fund | vc | Canada |
| ARK Venture Fund | vc | United States |
| EU Scaleup Fund | vc | Europe |
| Shanghai Future Industries Fund | vc | China |
| Marram Ventures | vc | United States |
| Elanco Ventures | corporate vc | United States |
| Kos Biotechnology Fund | vc | Greece |
| AV Seed Fund | vc | United States |
| Spinout Inspire Fund | vc | United Kingdom |
| spARK Labs Venture Fund | accelerator | United States |
◆ Startups in Biotech (68 tracked)
| Startup | Stage | HQ | Raised |
|---|---|---|---|
| Estuary Biotherapeutics | series-a | United States | $93M |
| Giraffe Bio | seed | Argentina | $6.4M |
| Metabolize | seed | United States | $3.2M |
| OlsAro | seed | Sweden | $11.1M |
| Molagri | seed | Canada | $5.8M |
| Drylab AI | seed | Singapore | $3M |
| Undecimal Bio | seed | United Kingdom | $18M |
| Precision Chroma | seed | New Zealand | $7.3M |
| BioLinker | seed | Brazil | $1.7M |
| SereNeuro Therapeutics | pre-seed | United States | — |
| ZoeNCure Therapeutics | seed | India | $2.1M |
| Pilgrim | seed | United States | $25M |
| Ordo Labs | seed | Sweden | $0.5M |
| Cascader Ltd | seed | United Kingdom | — |
| Kasvu Therapeutics | series-a | Finland | $34.4M |
| Azulene Labs | pre-seed | United States | $3.4M |
| Altis Labs | series-a | Canada | $25M |
| Biolevate | series-a | France | $34.4M |
| KBIOGATEWAY | seed | South Korea | $0.9M |
| MicroLub | — | United Kingdom | $10.0M |
| Robigo | series-a | United States | — |
| Axo Longevity | seed | United Kingdom | $5M |
| UCANACT | pre-seed | Netherlands | $0.9M |
| Mithrl | series-a | United States | $20M |
| BryoSphere Biotechnologies | seed | Canada | — |
Show all 50 startups
| Rainbow Crops | seed | Belgium | $11.3M |
| Halmos Labs | seed | Sweden | $0.5M |
| sci2sci | pre-seed | Germany | $1.4M |
| Ipremom | seed | Spain | $17.4M |
| ENA Respiratory | — | Australia | $3M |
| GonGlobal | pre-seed | Australia | $1.2M |
| Pharosyn | seed | United Kingdom | $2.8M |
| Frontier Computing | pre-seed | United Kingdom | $10M |
| Kimtechnix | — | South Korea | — |
| ABLE Labs | series-a | South Korea | $8.7M |
| Bioactivx | seed | Singapore | $3M |
| Adaptyv Bio | series-a | Switzerland | $40M |
| Transfyr | seed | United States | $25M |
| BioNexus | seed | South Korea | — |
| Arboreal Bioinnovations | series-a | India | $27.6M |
| Quercus Biosolutions | seed | United States | $5M |
| Zonova Technologies | seed | United Kingdom | — |
| Reme-D | pre-seed | Egypt | $1.4M |
| Elle, MD Technologies | pre-seed | Canada | $0.8M |
| Cheiron | seed | United States | $8M |
| Plantopia | — | Israel | — |
| Immitra Bio | pre-seed | Switzerland | $2.6M |
| Sightera Biosciences | pre-seed | Belgium | $3.3M |
| Mandrake Bio | pre-seed | India | $1.9M |
| Auxilium Health | seed | United States | $3.4M |
◆ Recent Wire analysis
- Kenya confirms four new Ebola cases, bringing total number to seven17 Oct 2026
- FDA approves UCB's ZILBRYSQ autoinjector for at-home self-administration in myasthenia gravis17 Oct 2026
- Vivacta Bio and Grit Bio Announce FDA Orphan Drug Designation for In Vivo CAR-T ...17 Oct 2026
- AI Steps Into RNA Drug Discovery, From Small Molecules to Oligonucleotide Therapeutics17 Oct 2026
- Nipocalimab in Myasthenia Gravis: Real-World Use, Long-Term Safety, and the Road Ahead17 Oct 2026
- Pancreatic cancer: Europe gives initial approval to a drug that doubles survival rates17 Oct 2026
- Saudi Arabia launches first Middle Eastern biological samples to space17 Oct 2026
- Bladder Cancer: FDA Expands Anktiva Without a New Trial17 Oct 2026
- ImmunityBio Stock In Focus After FDA Expands Anktiva Bladder Cancer Approval17 Oct 2026
- US FDA sets up board to oversee drug exclusivity determinations17 Oct 2026